These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2650421)

  • 21. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The production of adult chimeras by the use of monoclonal anti-host H-2K antibody.
    Wegmann TG; Carlson GA; Drell DW
    Transplant Proc; 1981 Mar; 13(1 Pt 1):654-6. PubMed ID: 7268886
    [No Abstract]   [Full Text] [Related]  

  • 23. The allogeneic effect in (Balb/c X AKR)F1 mice.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):423-7. PubMed ID: 6367696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of GVH reaction in F1 hybrid mice by foetal liver cells.
    Siegl E; Brock J; Schulze HA
    Folia Biol (Praha); 1982; 28(6):409-14. PubMed ID: 6761153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
    Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
    Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice.
    Goldman M; Abramowicz D; Lambert P; Vandervorst P; Bruyns C; Toussaint C
    Clin Exp Immunol; 1988 Apr; 72(1):79-83. PubMed ID: 3260841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of splenectomy on establishment of hematopoietic chimerism in nonirradiated mice.
    Tsuyama K; Tamai M; Ochi T; Kitamura Y
    Exp Hematol; 1982 Nov; 10(10):830-4. PubMed ID: 7151896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
    Clerici M; Villa ML; Clerici E
    Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of long-term transplantation tolerance, chimerism, and host-versus-graft disease: interrelationship and cellular requirements.
    DeNardin AM; Brentjens JR; Andres GA; Nakamura I
    Transplant Proc; 1989 Feb; 21(1 Pt 1):265-6. PubMed ID: 2784894
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of BALB/c donor CD8+ lymphocytes in graft-versus-host disease in (BALB/c x A/J)F1 (CAF1) mice.
    Vidal S; Labrador M; Rodríguez-Sánchez JL; Gelpí C
    J Immunol; 1996 Feb; 156(3):997-1005. PubMed ID: 8558027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits.
    Abramowicz D; Goldman M; Bruyns C; Lambert P; Thoua Y; Toussaint C
    Clin Exp Immunol; 1987 Oct; 70(1):61-7. PubMed ID: 3319303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
    Fast LD
    J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal analysis of T cell unresponsiveness to alloantigens induced by neonatal injection of F1 spleen cells into parental mice.
    Feng HM; Glasebrook AL; Engers HD; Louis JA
    J Immunol; 1983 Nov; 131(5):2165-9. PubMed ID: 6195253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of human CD40-Ig fusion protein in a murine model of acute graft-versus-host disease.
    Liu H; Mao N; Hou C; Li X; Shen B; Tang PH
    Chin Med J (Engl); 2001 Jul; 114(7):685-9. PubMed ID: 11780327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental studies of immunologically mediated enteropathy: IV. Correlation between immune effector mechanisms and type of enteropathy during a GvHR in neonatal mice of different ages.
    Felstein MV; Mowat AM
    Clin Exp Immunol; 1988 Apr; 72(1):108-12. PubMed ID: 3396213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.